Sílvia Gómez-Zorrilla

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Influence of Virulence Genotype and Resistance Profile in the Mortality of Pseudomonas aeruginosa Bloodstream Infections

Carmen Peña, Gabriel Cabot, Sílvia Gómez-Zorrilla et al. · Clinical Infectious Diseases · 2014 · 222 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain

Ester del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot et al. · Antimicrobial Agents and Chemotherapy · 2017 · 171 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros et al. · Journal of Antimicrobial Chemotherapy · 2019 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · Mayo Clinic Proceedings · 2016 · 117 citations

Life Sciences, Infectious Diseases, Microbiology +16